About this trial
Sleep is essential for our overall health and well-being, much like food and water. It plays a vital role in numerous bodily functions. Many studies have been conducted to determine the efficacy of melatonin congeners and Mg supplements in patients with insomnia separately. This study aims to compare the efficacy of melatonin and magnesium supplements in young adults with primary insomnia. Most insomnia studies focus on older adults or individuals with comorbidities. Targeting otherwise healthy young adults brings age-specific relevance and novel insight.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age 18-40 years
Gender: Male and Females (Non-pregnant & Non lactating)
Difficulty falling asleep, staying asleep or nonrestorative sleep
This difficulty is present despite adequate opportunity & circumstance to sleep
Disqualifiers
Insomnia due to a known underlying cause
Any psychiatric illness
Active use of sedative hypnotics
Trial design
Parallel
Treatments tested in this trial
Magnesium glycinate
DrugTab Magnesium glycinate 500mg will be given to one group for treatment of primary insomnia
Melatonin
DrugTab Melatonin 10mg will be given to the other group for treatment of primary insomnia
Treatment groups
Trial outcomes
Primary outcomes
Insomnia Severity Index (ISI)
ISI is a 7-item questionnaire used to determine the severity of insomnia.
Locations
1Map coordinates are unavailable for these locations. Locations are shown below instead.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.